Welcome to NewsHome

This website is intended for journalists or healthcare professionals outside the US/UK who are interested in media information from Boehringer Ingelheim. Please choose an option below:

I am a journalist or HCP outside the US/UKI am a journalist or HCP in the US/UKI am not a journalist or HCP
 
The Changing Face of Cancer Infographic thumb
 
Rating:00
view image larger
Related links:
Afatinib delivers first line efficacy in patients thumb
Afatinib delivers unprecedented first line efficacy
Read more >
LUX-Lung 3 Fact Sheet thumb
LUX-Lung 3 Fact Sheet
Read more >

The Changing Face of Cancer Infographic

01.05.2011

Prevalence trends in cancer - Global cancer incidence, mortality rates and future trends

Global cancer incidence and mortality rates continue to rise. In 2008 12.7 million patients were diagnosed with cancer while 7.6 million people died of the disease. These numbers are expected to rise to 21.4 million new cases and 13.2 million deaths by 2030.1,2

Evolution of treatments - traditional treatments to targeted therapies

Chemotherapy was one of the major medical advances of the second half of the 20th century. It's an indiscriminate treatment affecting both fast proliferating healthy and cancer cells. Targeted therapy recognises specific targets in or on cancer cells.

From an incurable disease to a chronic condition: changing cancer care We have seen improvements in cancer diagnosis, management and care. But still there is a high unmet medical need in certain types of cancer.

1. Ferlay J et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; EPub Ahead of print.
2. Malvezzi, M et al. European cancer mortality predictions for the year 2011: Annals of Oncology 2011 Feb 8. [Epub ahead of print].
3. National Cancer Institute. Surveillance Epidemiology and End Results. Available at: http://seer.cancer.gov/faststats/selections.php?series=age.
VIEW PREVIEW ADD TO SELECTION DOWNLOAD